| Fein Foot And Ankle Center | |
|
6243 Fairmont Pkwy Ste 203c, Pasadena, TX 77505-4047 | |
| (832) 301-9871 | |
| (281) 630-2954 |
| Full Name | Fein Foot And Ankle Center |
|---|---|
| Type | Facility |
| Speciality | Podiatrist - Foot & Ankle Surgery |
| Location | 6243 Fairmont Pkwy Ste 203c, Pasadena, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376035063 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 2324 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Fein Foot And Ankle Center 6243 Fairmont Pkwy Ste 203c, Pasadena, TX 77505-4047 Ph: (832) 301-9871 | Fein Foot And Ankle Center 6243 Fairmont Pkwy Ste 203c, Pasadena, TX 77505-4047 Ph: (832) 301-9871 |
News Archive
COVID-19 vaccines are the most effective way to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. For people who are already infected, new research suggests the small molecule stimulator of interferon genes (STING) agonist-1, diABZI, may be effective in controlling SARS-CoV-2 infection — including those caused by variants.
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that its wholly-owned contract research subsidiary, Shanghai ChemPartner, has signed an outsource research service agreement with Shenogen Pharma Group to develop therapeutic monoclonal antibodies targeting the ER-alpha 36 receptor for cancer treatment.
The University of Chicago will help lead an $8.8 million effort to make the vast quantity of cancer research data being produced more accessible and useful to clinicians and researchers around the world.
Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat chronic and acute wounds, today launched Microcyn Skin & Wound HydroGel for both the U.S. professional and over-the-counter markets. The Microcyn HydroGel received FDA 510(k) marketing clearance in May of this year.
› Verified 8 days ago
Dr. Scott W Mckinney, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3692 E Sam Houston Pkwy S, Suite 100, Pasadena, TX 77505 Phone: 713-946-1500 Fax: 713-946-0200 | |
Francisco J Cuza, D.P.M. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3692 E Sam Houston Pkwy S, Suite 100, Pasadena, TX 77505 Phone: 713-946-1500 Fax: 713-946-0200 | |
Dr. Edward M. Jacquet Iii, D.P.M. Podiatrist Medicare: Medicare Enrolled Practice Location: 5119 Fairmont Parkway, Suite B-2, Pasadena, TX 77505 Phone: 713-910-5577 Fax: 713-910-1992 | |
Texas Mobile Foot Consultants, Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3222 Burke Rd, Suite 102, Pasadena, TX 77504 Phone: 713-948-0400 Fax: 713-948-0401 | |
Dr. Jorge L Cuza, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3692 E Sam Houston Pkwy S, Suite 100, Pasadena, TX 77505 Phone: 713-946-1500 Fax: 713-946-0200 | |
Bruce Miller, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 6021 Fairmont Pkwy, Ste 130, Pasadena, TX 77505 Phone: 281-991-0600 Fax: 281-991-0638 |